Private Equity InvestorsDiligence and structuring at deal speed, with sector depth in hand.
Your diligence window is finite, the information advantage decays fast, and the competition for quality healthcare and pharma assets in the GCC is real. What the mandate needs is a buy-side advisor who is deployable now, with sector depth already in hand, not a team being assembled for the first time after the clock has started. Generalist advisors can run financial diligence in most sectors. GCC healthcare is not most sectors, and what they do not know about it is exactly the risk that reprices the deal after close.
What you engage us for
You engage Avior for integrated commercial, regulatory, and operational diligence on healthcare and pharma targets. The regulatory architecture (DHA in Dubai, DoH in Abu Dhabi, MOHAP at federal level, plus emirate-specific licensing) determines what the asset can do, what it would cost to fix, and whether the operational risk is priceable. Payer mix, physician-ownership restrictions, licensing portability, and staffing ratios create value and risk at once; standard EBITDA normalisation does not capture them. We also build the exit story before the process starts, and provide CFO-level support through a transition.
How we work
The principal delivers the diligence, the operational work, and the exit preparation. Not a team brought together for this engagement: a principal who has done this work before and carries the full analytical burden, at the speed your mandate runs. Post-close, we work the value-creation plan at the asset level, where clinical efficiency, procurement, and back-office consolidation separate what is achievable from what only looked good in the CIM.
Speed without depth is not an advantage. We hold both.
Further reading
Related insights
What earns a 10x healthcare multiple
Amanat's completion of full ownership of Cambridge Health Group at an implied ~10.5x EBITDA on our own arithmetic shows that scale and margin quality, not top-line revenue, are what command the platform multiple.
Deal BriefDiligence on a hospital group: what moves price
Diligence on a multi-site medical-center network or hospital group is a discipline in itself, and the findings that reprice a deal sit in payer concentration, denial rates, per-facility licence conditions, health-information connectivity, and the new UAE merger-control regime.
Deal BriefFinancing a buy-and-build healthcare platform
The right mix of debt and equity for a scaling hospital or medical-center-group platform depends on its cash generation and its stage, and the GCC's 2026 capital markets now offer sukuk, private equity, and staged structures to match each one.